Mabion Signs About 2 Mln Zloty Deal With WPD Pharmaceuticals
April 17 (Reuters) - Mabion SA MABP.WA:
SIGNS AGREEMENT WITH WPD PHARMACEUTICALS FOR ANALYTICAL METHOD DEVELOPMENT
DEAL VALUE SET AT ABOUT PLN 2.0 MILLION NET
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Recommended Articles
Featured Tools
Top News
ORCL Stock: Why Oracle May Be the Beaten-Down Tech Giant Ready for a Comeback

Nvidia Makes First Bet on Legal AI, Invests $50 Million in Legora

POET Technologies Stock Could Still Surge in 2026, but the Bar for a Breakout Is Higher Now

What Is Intel, and Is Its Stock Still a Worthwhile Investment?

Amazon vs. Microsoft: Which Stock Is a Better Buy for 2026 and Beyond?

Tradingkey







